Quality Use of Medicines Alliance expanding into new clinical topics

15 April 2025

 

The Pharmaceutical Society of Australia (PSA) is continuing its work as part of the Quality Use of Medicines Alliance, a multidisciplinary group of health and consumer organisations delivering free health education for a national audience of health professionals and consumers.

 

Building on its existing suite of resources, the QUM Alliance is expanding into new topic areas including menopause, secondary stroke prevention, antidepressants in teens and young adults, osteoporosis, and complex comorbidity.

 

Supported by the Australian Government’s Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program, the addition of these new topics builds on the work of the QUM Alliance in atopic dermatitis (eczema), gout, antidepressants in older people, and oral anticoagulants in people with atrial fibrillation over the past two years.

 

PSA National President Associate Professor Fei Sim FPS said: “PSA is proud to be a part of the QUM Alliance, championing the collaborative learning of all health professionals on some of Australia’s most prevalent health issues.”

 

“PSA is leading the way for QUM education, representing the pharmacy profession and working closely with other Alliance members to upskill not only pharmacists but also other health professionals and consumers.

 

“We look forward to continuing this important work over the next three years, and encourage pharmacists across all areas of practice to engage with the QUM Alliance resources,” Associate Professor Sim concluded.

 

 

Current PSA education offerings produced as part of the QUM Alliance are available here.

 

​

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au